Fatty acid study aims to unlock preterm baby development

NCT ID NCT05380401

Recruiting now Knowledge-focused Sponsor: The University of Texas Health Science Center at San Antonio Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study looks at how giving DHA and ARA supplements to very premature babies (born at 25 to 29 weeks) affects their metabolism and inflammation. Researchers will measure fatty acid levels and other biomarkers in blood. The goal is to understand how these nutrients work in the body, not to test a treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: DHA and ARA (dietary supplements)
What this could lead to: If successful, this could help doctors understand how these fatty acids support development in premature babies.
What could go wrong: This is an early-stage observational study, not a treatment trial. It measures biomarkers, not health outcomes, so benefits are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREMATURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PREMATURE

Contacts and locations

Locations

Ann & Robert H. Lurie Children's Hospital of Chicago
RECRUITING

Chicago, Illinois, 60611, United States
Northwestern University
RECRUITING

Chicago, Illinois, 60611, United States
University Health System
RECRUITING

San Antonio, Texas, 78229, United States
University of California, Los Angeles (UCLA)
RECRUITING

Los Angeles, California, 90404, United States
University of Texas Health Science Center at San Antonio
RECRUITING

San Antonio, Texas, 78229, United States
Weill Cornell Medicine
RECRUITING

New York, New York, 10021, United States
Yale New Haven Hospital
RECRUITING

New Haven, Connecticut, 06511, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.